Cost Effectiveness Analysis Of Apixaban Compared To Oral Anticoagulants In The Prevention Of Thromboembolic Events In Patients With Non-Valvular Atrial Fibrillation In Guatemala In 2014
May 1, 2015, 00:00
10.1016/j.jval.2015.03.825
https://www.valueinhealthjournal.com/article/S1098-3015(15)00882-7/fulltext
Title :
Cost Effectiveness Analysis Of Apixaban Compared To Oral Anticoagulants In The Prevention Of Thromboembolic Events In Patients With Non-Valvular Atrial Fibrillation In Guatemala In 2014
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00882-7&doi=10.1016/j.jval.2015.03.825
First page :
A142
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
264